These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22766120)

  • 1. Ultrasound histogram assessment of parotid gland injury following head-and-neck radiotherapy: a feasibility study.
    Yang X; Tridandapani S; Beitler JJ; Yu DS; Yoshida EJ; Curran WJ; Liu T
    Ultrasound Med Biol; 2012 Sep; 38(9):1514-21. PubMed ID: 22766120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of ultrasonic histogram features to evaluate radiation toxicity of the parotid glands: a clinical study of xerostomia following head-and-neck cancer radiotherapy.
    Yang X; Tridandapani S; Beitler JJ; Yu DS; Chen Z; Kim S; Bruner DW; Curran WJ; Liu T
    Acad Radiol; 2014 Oct; 21(10):1304-13. PubMed ID: 25088832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound GLCM texture analysis of radiation-induced parotid-gland injury in head-and-neck cancer radiotherapy: an in vivo study of late toxicity.
    Yang X; Tridandapani S; Beitler JJ; Yu DS; Yoshida EJ; Curran WJ; Liu T
    Med Phys; 2012 Sep; 39(9):5732-9. PubMed ID: 22957638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasonic Nakagami-parameter characterization of parotid-gland injury following head-and-neck radiotherapy: a feasibility study of late toxicity.
    Yang X; Tridandapani S; Beitler JJ; Yu DS; Wu N; Wang Y; Bruner DW; Curran WJ; Liu T
    Med Phys; 2014 Feb; 41(2):022903. PubMed ID: 24506650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic imaging biomarkers of postradiotherapy xerostomia.
    Cannon B; Schwartz DL; Dong L
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1609-16. PubMed ID: 22658215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can dose reduction to one parotid gland prevent xerostomia?--A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy.
    Anand AK; Jain J; Negi PS; Chaudhoory AR; Sinha SN; Choudhury PS; Kumar R; Munjal RK
    Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):497-504. PubMed ID: 16909975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early prediction of radiotherapy-induced parotid shrinkage and toxicity based on CT radiomics and fuzzy classification.
    Pota M; Scalco E; Sanguineti G; Farneti A; Cattaneo GM; Rizzo G; Esposito M
    Artif Intell Med; 2017 Sep; 81():41-53. PubMed ID: 28325604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations on parotid gland recovery after IMRT in head and neck tumor patients.
    Stock M; Dörr W; Stromberger C; Mock U; Koizar S; Pötter R; Georg D
    Strahlenther Onkol; 2010 Dec; 186(12):665-71. PubMed ID: 21136030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results.
    Eisbruch A; Ship JA; Martel MK; Ten Haken RK; Marsh LH; Wolf GT; Esclamado RM; Bradford CR; Terrell JE; Gebarski SS; Lichter AS
    Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):469-80. PubMed ID: 8892473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique.
    Amosson CM; Teh BS; Van TJ; Uy N; Huang E; Mai WY; Frolov A; Woo SY; Chiu JK; Carpenter LS; Lu HH; Grant WH; Butler EB
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):136-44. PubMed ID: 12694832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early changes of parotid density and volume predict modifications at the end of therapy and intensity of acute xerostomia.
    Belli ML; Scalco E; Sanguineti G; Fiorino C; Broggi S; Dinapoli N; Ricchetti F; Valentini V; Rizzo G; Cattaneo GM
    Strahlenther Onkol; 2014 Oct; 190(11):1001-7. PubMed ID: 24756139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: correlations with parotid dose and quality of life.
    Chen WC; Lai CH; Lee TF; Hung CH; Liu KC; Tsai MF; Wang WH; Chen H; Fang FM; Chen MF
    Oral Oncol; 2013 Jan; 49(1):42-8. PubMed ID: 22854066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of sonographic appearance of normal and postradiotherapy parotid glands: a preliminary study.
    Ying M; Wu VW; Kwong DL
    Ultrasound Med Biol; 2007 Aug; 33(8):1244-50. PubMed ID: 17466447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
    Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delta-radiomics features during radiotherapy improve the prediction of late xerostomia.
    van Dijk LV; Langendijk JA; Zhai TT; Vedelaar TA; Noordzij W; Steenbakkers RJHM; Sijtsema NM
    Sci Rep; 2019 Aug; 9(1):12483. PubMed ID: 31462719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy.
    Rudat V; Münter M; Rades D; Grötz KA; Bajrovic A; Haberkorn U; Brenner W; Debus J
    Radiother Oncol; 2008 Oct; 89(1):71-80. PubMed ID: 18707782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parotid gland fat related Magnetic Resonance image biomarkers improve prediction of late radiation-induced xerostomia.
    van Dijk LV; Thor M; Steenbakkers RJHM; Apte A; Zhai TT; Borra R; Noordzij W; Estilo C; Lee N; Langendijk JA; Deasy JO; Sijtsema NM
    Radiother Oncol; 2018 Sep; 128(3):459-466. PubMed ID: 29958772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal assessment of parotid function in patients receiving tomotherapy for head-and-neck cancer.
    Voordeckers M; Everaert H; Tournel K; Verellen D; Baron I; Van Esch G; Vanhove C; Storme G
    Strahlenther Onkol; 2008 Aug; 184(8):400-5. PubMed ID: 18956516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation-induced damage to microstructure of parotid gland: evaluation using high-resolution magnetic resonance imaging.
    Kan T; Kodani K; Michimoto K; Fujii S; Ogawa T
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1030-8. PubMed ID: 19879064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scintigraphic evaluation of long-term salivary function after bilateral whole parotid gland irradiation in radiotherapy for head and neck tumour.
    Kaneko M; Shirato H; Nishioka T; Ohmori K; Takinami S; Arimoto T; Kagei K; Miyasaka K; Nakamura M
    Oral Oncol; 1998 Mar; 34(2):140-6. PubMed ID: 9682778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.